Chip Moore
Hand Surgery · Abilene, TXNPI 1104314111
Payments from drug & device makers
What this record shows
This record is dominated by education: $12,952 of the $16,331 with a category attached, or 79.3%. Pylant Medical accounts for 83.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $8,195 and has fallen 93.7% since, to $520 in 2025.
Across 69 payments — averaging $236.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$14K
- Axogen$943
- Stryker$902
- Arthrex$185
- Cerapedics Inc.$168
- Skeletal Dynamics Inc$92
- plus $468 from 14 others
What the payments were for
- Travel & lodging$5203%
- Food & beverage$2,86018%
- Education$12,95279%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 17 | $13,574 |
| Axogen | 15 | $943 |
| Stryker | 11 | $902 |
| Arthrex | 2 | $185 |
| Cerapedics Inc. | 1 | $168 |
| Skeletal Dynamics Inc | 1 | $92 |
| Vertex | 3 | $75 |
| Arthrosurface Incorporated | 2 | $73 |
| Amgen | 3 | $66 |
| AbbVie | 2 | $50 |
| Pacira Pharmaceuticals Incorporated | 3 | $49 |
| Molnlycke Health Care US, LLC | 1 | $23 |
| Anika Therapeutics, Inc. | 1 | $21 |
| Endo USA, Inc. | 1 | $20 |
| Curonix LLC | 1 | $20 |
| Organogenesis Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $14 |
| Advanced Oxygen Therapy Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,331 in reported general payments places this provider in the 80th percentile of 170 hand surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 29 | $263 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $133 |
| Gabapentin | 11 | $84 |
| Oxycodone Hcl | 13 | $72 |
| Tramadol Hcl | 11 | $63 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $61 |
| Cephalexin | 13 | $60 |
| Ibuprofen | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Abilene
- David RingAustin$536K
- Kourosh JafarniaHouston$278K
- Brendan MackayLubbock$274K
- John FaillaceWoodway$212K
- Daniel KoehlerDallas$208K
- Timothy NiacarisArlington$160K
- Steven NiedermeierArlington$152K
- William PientkaFort Worth$113K
- Ann GoldenDallas$107K
- Cameron AtkinsonArlington$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.